New drugs are continually being researched and developed for Non-Hodgkin’s lymphoma. These must be shown to be safe and effective before doctors can prescribe them to patients. Through clinical trials, researchers test the effects of new drugs on a group of volunteers with non-Hodgkin’s lymphoma. Following a strict protocol and using carefully controlled conditions, researchers evaluate the investigational drugs under development and measure the ability of the new drug to treat non-Hodgkin’s lymphoma, its safety, and any possible side effects.
Some patients with non-Hodgkin’s lymphoma are reluctant to take part in clinical trials for fear of getting no treatment at all for their condition. Patients who participate in clinical trials may receive the most effective therapy available for their condition -- or they may receive treatments that are being evaluated for future use. These drugs may be even more effective than the current non-Hodgkin’s lymphoma treatment. The specifics of the clinical trial should be discussed with your doctor.
The following web sites offer information and services to help you find a non-Hodgkin’s lymphoma clinical trial that is right for you.
This web site, developed by the nonprofit Coalition of Cancer Cooperative Groups, is an unbiased cancer clinical trial matching and navigation service enabling patients to search for cancer trials based on disease and location.
This web site lists more than 6,000 cancer clinical trials and explains what to do when you find one that you think is right for you.
This web site offers up-to-date information for locating federally and privately supported clinical trials for cancer.
This web site lists industry-sponsored clinical trials that are actively recruiting patients.